Where can I learn more about this study?

You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.
- www.clinicaltrials.gov. Once you are on the website, type "NCT04078126" into the search box and click "Search".
- www.clinicaltrialsregister.eu. Once you are on the website, click "Home and Search", then type "2019-001801-26" in the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D5980C00023" into the search box and click "Find a Study".

Full Study Title: A Randomized, Open-Label, Two Period Crossover, Chronic Dosing, 1-Week, Pilot Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Inhalation Aerosol Administered with a Spacer Compared with Symbicort® Turbuhaler® in Subjects with Severe to Very Severe Chronic Obstructive Pulmonary Disease and Low Peak Inspiratory Flow

AstraZeneca Protocol Number: D5980C00023

National Clinical Trials Number: NCT04078126

EudraCT Number: 2019-001801-26

AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.

CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org

Version 1.0 2021_10_22